Senior insider sale
Chief Business Officer at JANUX THERAPEUTICS, INC. — senior position signals high conviction
$5.08M
322.10K shares
What this filing means
MEYER ANDREW HOLLMAN plans to sell 322.10K shares of JANUX THERAPEUTICS, INC. valued at approximately $5.08M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/26/2026ACC: 0001950047-26-000670
Officer· Chief Business Officer
Since Jun 2021
322.10K
Shares to sell
$5.08M
Approx. market value
178.77K
Acquired (3 months)
1
Planned
5 completed
Securities Acquired — Last 3 Months1
Exercise of options under a registered plan
Cash
1/26/2026
178.77KTotal acquired178.77K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/26/2026 | Exercise of options under a registered plan Cash | 178.77K | — |
| Total | 178.77K | ||
Planned & Completed Dispositions6
Completed
—Completed
Units to sell
118.12K
Market value
$1.74M
1/23/2026
—Completed
Units to sell
1.88K
Market value
$25.8K
1/2/2026
—Completed
Units to sell
3.33K
Market value
$109.8K
12/1/2025
—Completed
Units to sell
3.33K
Market value
$99.8K
11/14/2025
—Completed
Units to sell
16.66K
Market value
$500.3K
10/28/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
178.77K
Market value
$2.60M
1/26/2026
Total
Units
322.10K
Value
$5.08M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/23/2026 | 118.12K | $1.74M | — | Completed |
1/2/2026 | 1.88K | $25.8K | — | Completed |
12/1/2025 | 3.33K | $109.8K | — | Completed |
11/14/2025 | 3.33K | $99.8K | — | Completed |
10/28/2025 | 16.66K | $500.3K | — | Completed |
| Planned — Approximate Date | ||||
1/26/2026 | 178.77K | $2.60M | NASDAQ | Planned |
| Total | 322.10K | $5.08M | ||